The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Athanassios Argiris

Division of Hematology-Oncology

Department of Medicine

University of Pittsburgh School of Medicine

Pittsburgh

Pennsylvania

[email]@upmc.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 2005 - 2011
  • Biostatistics Facility, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232, USA. 2010 - 2011
  • Division of Hematology-Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, USA. 2006

References

  1. A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: A trial of the eastern cooperative oncology group (E1303). Argiris, A., Ghebremichael, M., Burtness, B., Axelrod, R.S., Deconti, R.C., Forastiere, A.A. Cancer (2011) [Pubmed]
  2. Phase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer. Argiris, A., Karamouzis, M.V., Gooding, W.E., Branstetter, B.F., Zhong, S., Raez, L.E., Savvides, P., Romkes, M. J. Clin. Oncol. (2011) [Pubmed]
  3. Empowering induction therapy for locally advanced head and neck cancer. Argiris, A., Karamouzis, M.V. Ann. Oncol. (2011) [Pubmed]
  4. Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer. Argiris, A., Heron, D.E., Smith, R.P., Kim, S., Gibson, M.K., Lai, S.Y., Branstetter, B.F., Posluszny, D.M., Wang, L., Seethala, R.R., Dacic, S., Gooding, W., Grandis, J.R., Johnson, J.T., Ferris, R.L. J. Clin. Oncol. (2010) [Pubmed]
  5. Docetaxel and irinotecan in recurrent or metastatic head and neck cancer: a phase 2 trial of the Eastern Cooperative Oncology Group. Argiris, A., Buchanan, A., Brockstein, B., Kolesar, J., Ghebremichael, M., Pins, M., Hahn, K., Axelrod, R., Forastiere, A. Cancer (2009) [Pubmed]
  6. Long-term results of a phase III randomized trial of postoperative radiotherapy with or without carboplatin in patients with high-risk head and neck cancer. Argiris, A., Karamouzis, M.V., Johnson, J.T., Heron, D.E., Myers, E., Eibling, D., Cano, E., Urba, S., Gluckman, J., Grandis, J.R., Wang, Y., Agarwala, S.S. Laryngoscope (2008) [Pubmed]
  7. A phase II trial of doxorubicin and interferon alpha 2b in advanced, non-medullary thyroid cancer. Argiris, A., Agarwala, S.S., Karamouzis, M.V., Burmeister, L.A., Carty, S.E. Invest. New. Drugs (2008) [Pubmed]
  8. Combined analysis of molecular and clinical predictors of gefitinib activity in advanced non-small cell lung cancer: epidermal growth factor receptor mutations do not tell the whole story. Argiris, A., Hensing, T., Yeldandi, A., Patel, S., Raji, A., Sturgis, C., Masters, G., Gooding, W., Pins, M., Kolesar, J. J. Thorac. Oncol (2006) [Pubmed]
  9. A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer. Argiris, A., Cohen, E., Karrison, T., Esparaz, B., Mauer, A., Ansari, R., Wong, S., Lu, Y., Pins, M., Dancey, J., Vokes, E. Cancer Biol. Ther. (2006) [Pubmed]
  10. Induction chemotherapy for head and neck cancer: will history repeat itself?. Argiris, A. J. Natl. Compr. Canc. Netw (2005) [Pubmed]
 
WikiGenes - Universities